ORGS · As filed with the SEC

Orgenesis income statement, by quarter

The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Comprehensive Loss (Income) · USD thousands, except per-share amounts

USD thousands, except per-share amounts	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	Q2 2024^† 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024	Q4 2023^† 3 months ended Dec 31, 2023
Customer D (United States)	301^†	347	246	141	165^†
Cost of Revenue	313^†	585	538	492	162^†
Gross loss	(12)^†	(238)	(292)	(351)	3^†
Research and Development Expense	1,240^†	4,523	1,489	2,370	3,007^†
Amortization of Intangibles	153^†	196	226	153	153^†
Change in Contingent consideration	(4,906)^†	81	182	—	—
Selling, General and Administrative Expense	4,041^†	2,664	2,061	6,056	2,145^†
Asset Impairment Charges	—	692	—	—	—
Share in net loss of associated companies	—	—	—	—	182^†
Operating loss	18,194^†	8,394	4,250	8,930	6,735^†
Loss (profit) from deconsolidation of OBI, Korea, Belgium, Services and Octomera (see note 3 and note 20)	(4,546)^†	0^†	0^†	66	0^†
Other income, net	(720)^†	122	(8)	—	0^†
Loss from extinguishment in connection with loans	5,281^†	0^†	0^†	141	0^†
Credit loss on convertible loan receivable	—	—	—	—	0^†
Financial expenses, net	2,123^†	718	815	852	581^†
Convertible loans induced conversion expenses	—	0^†	4,304	—	—
Loss before income taxes	20,332^†	9,234	9,361	9,989	6,764^†
Income Tax Expense	44^†	32	5	16	(141)^†
Net loss	20,376^†	9,266	9,366	10,005	6,623^†
Net Income Attributable to Noncontrolling Interest	0^†	(146)	(462)	(240)	0^†
Net loss attributable to Orgenesis Inc.	20,376^†	9,120	8,904	9,765	6,623^†
Earnings Per Share (Basic)	—	1.93	0.23	0.29	—
Earnings Per Share (Diluted)	—	1.93	0.23	0.29	—
Shares Outstanding
Basic	—	4,715,229	38,860,727	33,176,657	—
Diluted	—	4,715,229	38,860,727	33,176,657	—
Net loss	—	9,266	9,366	10,005	—
Comprehensive loss:
Other Comprehensive loss – Translation adjustment	(1,133)^†	517	(176)	(61)	6^†
Release of translation adjustment due to deconsolidation of Orgenesis Korea and the Belgian Subsidiary in 2024 (Octomera in 2023)	—	—	—	—	0^†
Comprehensive loss	—	9,783	9,190	9,944	6,629^†
Comprehensive loss attributed to non-controlling interests	—	(146)	(462)	(240)	0^†
Comprehensive loss attributed to Orgenesis Inc.	19,777^†	9,637	8,728	9,704	6,629^†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.